Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
PFZ On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John D. Young

Group President of Global Established Pharma Business, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

49$7,250,187
As of Fiscal Year 2014

Background*

Mr. John D. Young has been a Group President of Global Established Pharma Business at Pfizer Inc. since January 1, 2014. Mr. Young served as President and General Manager of Primary Care Business Unit at Pfizer Inc. from June 1, 2012 to December 2013. He served as Regional President of Europe and Canada for The Primary Care Business at Pfizer Inc. from 2009 to June 1, 2012. Over his 25-year career with Pfizer, Mr. Young has held a number of commercial positions with ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

Salary$1,040,000
Total Annual Compensation$1,040,000

Stock Options*

Restricted Stock Awards$1,813,518
All Other Compensation$326,498
Exercised Options88,906
Exercised Options Value$1,469,951
Exercisable Options218,654
Exercisable Options Value$2,217,643
Unexercisable Options594,320
Unexercisable Options Value$1,802,456
Total Value of Options$5,490,049
Total Number of Options901,880

Total Compensation*

Total Annual Cash Compensation$2,626,498
Total Short Term Compensation$1,040,000
Other Long Term Compensation$2,140,016
Total Calculated Compensation$7,250,187
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFZ:LN $0.00 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Paul Bulcke B.E.Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee
Nestlé S.A.
SFr.5.7M
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$6.4M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.3M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.